Intermittent hypoxia

Last updated
Intermittent hypoxia
Hypoxia protocol.png
Example of a typical intermittent hypoxia protocol
Other namesEpisodic hypoxia

Intermittent hypoxia (also known as episodic hypoxia) is an intervention in which a person or animal undergoes alternating periods of normoxia and hypoxia. Normoxia is defined as exposure to oxygen levels normally found in Earth's atmosphere (~21% O2) and hypoxia as any oxygen levels lower than those of normoxia. Normally, exposure to hypoxia is negatively associated to physiological changes to the body, such as altitude sickness. [1] However, when used in moderation, intermittent hypoxia may be used clinically as a means to alleviate various pathological conditions. [2]

Contents

General Mechanisms

The bifurcation of the carotid artery where the carotid body would be located. Gray's Anatomy with markup showing carotid artery bifurcation.png
The bifurcation of the carotid artery where the carotid body would be located.

When used as a rehabilitative intervention, particularly for respiration and walking, intermittent hypoxia typically works by using long-term facilitation (LTF). LTF, which is synonymous to long-term potentiation, occurs when there are long-term increases in synaptic strength due to synaptic plasticity. [3] In the case of intermittent hypoxia, these increases in synaptic strength result in increased motor output. [4] [5]

Reduced partial pressures of oxygen in the arteries due to intermittent hypoxia are sensed by and stimulate the carotid body, a chemoafferent receptor. [6] [7] The activated carotid body triggers the release of serotonin that attach to serotonin receptors on the surface of motoneurons, such as the phrenic motoneuron in the case of respiratory recovery. [5] This signal transduction pathway then uses downstream molecules such as TrkB, [8] BDNF, [8] and PKA [9] to increase the synaptic output of the involved motor neuron which in turn increases the motor output of the involved muscles and, thus, decreases functional impairment. As the amount of intermittent hypoxia changes the amount of serotonin release and, as a result, the amount of LTF, this process exhibits metaplasticity. [10] Metaplasticity occurs when the LTF is itself plastic or variable.

Intermittent hypoxia-induced LTF has also been demonstrated in carotid denervated rats, suggesting that synaptic plasticity due to intermittent hypoxia also works through other mechanisms outside of carotid chemoafferents. [11]

Aside from this, intermittent hypoxia also alters overall nitric oxide production, concentration, and gene expression, which occurs due to cardiovascular adaptations to hypoxia. [12] This mechanism is relevant when used as a means to decrease hypertension [13] or increase bone mineral density [14]

Dosage

Types of IH dosage [2]
TypeExample
Hypoxia severityFiO2 of 0.10
Episodic duration1 minute per episode
Episodes per day10 episodes/day
Pattern of presentationEvery other day
Cumulative exposure duration24 cumulative hours

An understanding of proper dosage is needed in order to design an effective intermittent hypoxia protocol, particularly due to the comorbidities associated with hypoxia. For example, intermittent hypoxia has been shown to induce LTF in rats while continuous hypoxia does not. [15] And acute IH shows no evidence of the hippocampal cell death found in rats while chronic intermittent hypoxia exposure does [16]

Though intermittent hypoxia has been used for various therapeutic applications across a number of physiological system, there is a general consensus in what can be considered a safe and beneficial amount of intermittent hypoxia. Such a protocol would involve a fraction of inspired oxygen (FiO2) ranging between 0.09 – 0.16 with 3 – 15 episodes per day with comorbidities found in the range of a FiO2 of 0.03 – 0.08 and 48 – 2400 episodes per day. [2]

Pathological and beneficial effects

Pathological effects [2] Beneficial effects [2]
Systemic hypertension Decrease arterial hypertension
Obesity Weight loss
Insulin resistance Increase glucose tolerance
Increase sympathetic activationStrengthen immune response
Cognitive deficitsEnhance spatial learning and memory
Inflammation Decrease inflammation

Therapeutic applications

COPD vs. healthy lung. Copd versus healthy lung.jpg
COPD vs. healthy lung.

Though intermittent hypoxia is initially involved with only the respiratory system, its downstream effects allow it to also be used as an effective rehabilitative intervention in a number of different biological systems in both animals and humans.

LTF

For the respiratory system, the LTF facilitated by intermittent hypoxia aids in increasing phrenic motor nerve output. This has been shown to help people with obstructive sleep apnea [17] and COPD. [18] The ability to increase muscle activity, specifically for walking, has also been demonstrated in both rats [16] and humans [19] after spinal cord injury.

Hippocampal neurogenesis

Hippocampal neurogenesis has also been demonstrated in rats subjected to intermittent hypoxia. This neurogenesis has shown related cognitive improvements such as enhanced learning and memory [20] [21] as well as overall increases in spatial cognitive ability. [22] Additionally, antidepressant-like effects are exhibited in rats undergoing such treatment. [23]

Nitric oxide production

Nitric oxide level changes due to intermittent hypoxia also provide potential benefits. People with hypertension have shown decreases in blood pressure. [13] [24] Increases in bone mineral density in rats has also been attributed to this process. [14] Such changes to nitric oxide levels also aid in protection from myocardial ischemia and perfusion. [25]

See also

Related Research Articles

<span class="mw-page-title-main">Neurotoxin</span> Toxin harmful to nervous tissue

Neurotoxins are toxins that are destructive to nerve tissue. Neurotoxins are an extensive class of exogenous chemical neurological insults that can adversely affect function in both developing and mature nervous tissue. The term can also be used to classify endogenous compounds, which, when abnormally contacted, can prove neurologically toxic. Though neurotoxins are often neurologically destructive, their ability to specifically target neural components is important in the study of nervous systems. Common examples of neurotoxins include lead, ethanol, glutamate, nitric oxide, botulinum toxin, tetanus toxin, and tetrodotoxin. Some substances such as nitric oxide and glutamate are in fact essential for proper function of the body and only exert neurotoxic effects at excessive concentrations.

<span class="mw-page-title-main">Long-term potentiation</span> Persistent strengthening of synapses based on recent patterns of activity

In neuroscience, long-term potentiation (LTP) is a persistent strengthening of synapses based on recent patterns of activity. These are patterns of synaptic activity that produce a long-lasting increase in signal transmission between two neurons. The opposite of LTP is long-term depression, which produces a long-lasting decrease in synaptic strength.

In neurophysiology, long-term depression (LTD) is an activity-dependent reduction in the efficacy of neuronal synapses lasting hours or longer following a long patterned stimulus. LTD occurs in many areas of the CNS with varying mechanisms depending upon brain region and developmental progress.

A chemoreceptor, also known as chemosensor, is a specialized sensory receptor which transduces a chemical substance to generate a biological signal. This signal may be in the form of an action potential, if the chemoreceptor is a neuron, or in the form of a neurotransmitter that can activate a nerve fiber if the chemoreceptor is a specialized cell, such as taste receptors, or an internal peripheral chemoreceptor, such as the carotid bodies. In physiology, a chemoreceptor detects changes in the normal environment, such as an increase in blood levels of carbon dioxide (hypercapnia) or a decrease in blood levels of oxygen (hypoxia), and transmits that information to the central nervous system which engages body responses to restore homeostasis.

<span class="mw-page-title-main">Carotid body</span>

The carotid body is a small cluster of chemoreceptor cells and supporting sustentacular cells situated at bifurcation of each common carotid artery in its adventitia.

Agmatine, also known as 4-aminobutyl-guanidine, was discovered in 1910 by Albrecht Kossel. It is a chemical substance which is naturally created from the amino acid arginine. Agmatine has been shown to exert modulatory action at multiple molecular targets, notably: neurotransmitter systems, ion channels, nitric oxide (NO) synthesis and polyamine metabolism and this provides bases for further research into potential applications.

Retrograde signaling in biology is the process where a signal travels backwards from a target source to its original source. For example, the nucleus of a cell is the original source for creating signaling proteins. During retrograde signaling, instead of signals leaving the nucleus, they are sent to the nucleus. In cell biology, this type of signaling typically occurs between the mitochondria or chloroplast and the nucleus. Signaling molecules from the mitochondria or chloroplast act on the nucleus to affect nuclear gene expression. In this regard, the chloroplast or mitochondria act as a sensor for internal external stimuli which activate a signaling pathway.

<span class="mw-page-title-main">Endocannabinoid system</span> Biological system of neurotransmitters

The endocannabinoid system (ECS) is a biological system composed of endocannabinoids, which are endogenous lipid-based retrograde neurotransmitters that bind to cannabinoid receptors, and cannabinoid receptor proteins that are expressed throughout the vertebrate central nervous system and peripheral nervous system. The endocannabinoid system remains under preliminary research, but may be involved in regulating physiological and cognitive processes, including fertility, pregnancy, pre- and postnatal development, various activity of immune system, appetite, pain-sensation, mood, and memory, and in mediating the pharmacological effects of cannabis. The ECS plays an important role in multiple aspects of neural functions, including the control of movement and motor coordination, learning and memory, emotion and motivation, addictive-like behavior and pain modulation, among others.

The preBötzinger complex, often abbreviated as preBötC, is a functionally and anatomically specialized site in the ventral-lateral region of the lower medulla oblongata. The preBötC is part of the ventral respiratory group of respiratory related interneurons. Its foremost function is to generate the inspiratory breathing rhythm in mammals. In addition, the preBötC is widely and paucisynaptically connected to higher brain centers that regulate arousal and excitability more generally such that respiratory brain function is intimately connected with many other rhythmic and cognitive functions of the brain and central nervous system. Further, the preBötC receives mechanical sensory information from the airways that encode lung volume as well as pH, oxygen, and carbon dioxide content of circulating blood and the cerebrospinal fluid.

<span class="mw-page-title-main">CX614</span> Chemical compound

CX-614 is an ampakine drug developed by Cortex Pharmaceuticals. It has been investigated for its effect on AMPA receptors.

<span class="mw-page-title-main">Nitric oxide synthase 2 (inducible)</span> Protein-coding gene in the species Homo sapiens

Nitric oxide synthase, inducible is an enzyme which is encoded by the NOS2 gene in humans and mice.

<span class="mw-page-title-main">8-OH-DPAT</span> Chemical compound

8-OH-DPAT is a research chemical of the aminotetralin chemical class which was developed in the 1980s and has been widely used to study the function of the 5-HT1A receptor. It was one of the first major 5-HT1A receptor full agonists to be discovered.

A hypoxicator is a medical device intended to provide a stimulus for the adaptation of an individual's cardiovascular system by means of breathing reduced oxygen hypoxic air and triggering mechanisms of compensation. The aim of intermittent hypoxic training or hypoxic therapy conducted with such a device is to obtain benefits in physical performance and wellbeing through improved oxygen metabolism.

In mammals, the Bötzinger complex (BötC) is a group of neurons located in the rostral ventrolateral medulla, and ventral respiratory column. In the medulla, this group is located caudally to the facial nucleus and ventral to nucleus ambiguus.

Hypoxic ventilatory response (HVR) is the increase in ventilation induced by hypoxia that allows the body to take in and transport lower concentrations of oxygen at higher rates. It is initially elevated in lowlanders who travel to high altitude, but reduces significantly over time as people acclimatize. In biological anthropology, HVR also refers to human adaptation to environmental stresses resulting from high altitude.

Intermittent hypoxic training (IHT), also known as intermittent hypoxic therapy, is a technique aimed at improving human performance by way of adaptation to reduced oxygen.

<i>S</i>-Nitrosoglutathione Chemical compound

S-Nitrosoglutathione (GSNO) is an endogenous S-nitrosothiol (SNO) that plays a critical role in nitric oxide (NO) signaling and is a source of bioavailable NO. NO coexists in cells with SNOs that serve as endogenous NO carriers and donors. SNOs spontaneously release NO at different rates and can be powerful terminators of free radical chain propagation reactions, by reacting directly with ROO• radicals, yielding nitro derivatives as end products. NO is generated intracellularly by the nitric oxide synthase (NOS) family of enzymes: nNOS, eNOS and iNOS while the in vivo source of many of the SNOs is unknown. In oxygenated buffers, however, formation of SNOs is due to oxidation of NO to dinitrogen trioxide (N2O3). Some evidence suggests that both exogenous NO and endogenously derived NO from nitric oxide synthases can react with glutathione to form GSNO.

Fish are exposed to large oxygen fluctuations in their aquatic environment since the inherent properties of water can result in marked spatial and temporal differences in the concentration of oxygen. Fish respond to hypoxia with varied behavioral, physiological, and cellular responses to maintain homeostasis and organism function in an oxygen-depleted environment. The biggest challenge fish face when exposed to low oxygen conditions is maintaining metabolic energy balance, as 95% of the oxygen consumed by fish is used for ATP production releasing the chemical energy of nutrients through the mitochondrial electron transport chain. Therefore, hypoxia survival requires a coordinated response to secure more oxygen from the depleted environment and counteract the metabolic consequences of decreased ATP production at the mitochondria.

Endothelial activation is a proinflammatory and procoagulant state of the endothelial cells lining the lumen of blood vessels. It is most characterized by an increase in interactions with white blood cells (leukocytes), and it is associated with the early states of atherosclerosis and sepsis, among others. It is also implicated in the formation of deep vein thrombosis. As a result of activation, enthothelium releases Weibel–Palade bodies.

Gaseous signaling molecules are gaseous molecules that are either synthesized internally (endogenously) in the organism, tissue or cell or are received by the organism, tissue or cell from outside and that are used to transmit chemical signals which induce certain physiological or biochemical changes in the organism, tissue or cell. The term is applied to, for example, oxygen, carbon dioxide, sulfur dioxide, nitrous oxide, hydrogen cyanide, ammonia, methane, hydrogen, ethylene, etc.

References

  1. ↑ FSF Editorial Staff (May–June 1997). "Wheel-well Stowaways Risk Lethal Levels of Hypoxia and Hypothermia" (PDF). Human Factors and Aviation Medicine. 44 (3): 2.
  2. 1 2 3 4 5 Navarette-Opazo, A.; Mitchell, G.S. (2014). "Therapeutic potential of intermittent hypoxia: a matter of dose". Am J Physiol Regul Integr Comp Physiol. 307 (10): R1181–1197. doi:10.1152/ajpregu.00208.2014. PMC   4315448 . PMID   25231353.
  3. ↑ Kandel, E.R. (2001). "The molecular biology of memory storage: A dialogue between genes and synapses". Science. 294 (5544): 1030–1038. Bibcode:2001Sci...294.1030K. CiteSeerX   10.1.1.322.6795 . doi:10.1126/science.1067020. PMID   11691980. S2CID   52799866.
  4. ↑ Hayashi, F.; Coles, S.K.; Bach, K.B.; Mitchell, G.S.; McCrimmon, D.R. (1993). "Time-dependent phrenic nerve responses to carotid afferent activation: intact vs. decerebellate rats". Am J Physiol Regul Integr Comp Physiol. 265 (4): R811–819. doi:10.1152/ajpregu.1993.265.4.R811. PMID   8238451.
  5. 1 2 Fuller, D.D.; Bach, K.B.; Baker, T.L.; Kinkead, R.; Mitchell, G.S. (2000). "Long term facilitation of phrenic motor output". Respir Physiol. 121 (2–3): 135–146. doi:10.1016/S0034-5687(00)00124-9. PMID   10963770.
  6. ↑ Millhorn, D.E.; Eldridge, F.L.; Waldrop, T.G. (1980). "Prolonged stimulation of respiration by a new central neural mechanism". Respir Physiol. 41 (1): 87–103. doi:10.1016/0034-5687(80)90025-0. PMID   6771859.
  7. ↑ Fuller, D.D.; Zabka, A.G.; Baker, T.L.; Mitchell, G.S. (2001). "Phrenic long-term facilitation requires 5-HT receptor activation during but not following episodic hypoxia". J Appl Physiol. 90 (5): 2001–2006. doi: 10.1152/jappl.2001.90.5.2001 . PMID   11299296.
  8. 1 2 Baker-Herman, T.L.; Fuller, D.D.; Bavis, R.W.; Zabka, A.G.; Golder, F.J.; Doperalski, N.J.; Johnson, R.A.; Watters, J.J.; Mitchell, G.S. (2004). "BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia". Nat Neurosci. 7 (1): 48–55. doi:10.1038/nn1166. PMID   14699417. S2CID   22965093.
  9. ↑ Hoffman, M.S.; Mitchell, G.S. (2011). "Spinal 5-HT7 receptor activation induces long-lastingphrenic motor facilitation". J Physiol. 589 (6): 1397–1407. doi:10.1113/jphysiol.2010.201657. PMC   3082099 . PMID   21242254.
  10. ↑ Wilkerson, J.E.; Mitchell, G.S. (2009). "Daily intermittent hypoxia augments spinal BDNF levels, ERK phosphorylation and respiratory long-term facilitation". Exp Neurol. 217 (1): 116–123. doi:10.1016/j.expneurol.2009.01.017. PMC   2691872 . PMID   19416672.
  11. ↑ Sibigtroth, C.M.; Mitchell, G.S. (2011). "Carotid chemoafferent activity is not necessary for all phrenic long-term facilitation following acute intermittent hypoxia". Respir Physiol Neurobiol. 176 (3): 73–79. doi:10.1016/j.resp.2010.11.006. PMC   4374991 . PMID   21093615.
  12. ↑ Manukhina, D.B.; Downey, H.F.; Mallet, R.T. (2006). "Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia". Exp Biol Med. 231 (4): 343–365. doi:10.1007/0-387-29540-2_6. PMID   16565431.
  13. 1 2 Lyamina, N.P.; Lyamina, S.V.; Senchiknin, V.N.; Mallet, R.T.; Downey, H.F.; Manukhina, E.B. (2011). "Normobaric hypoxia conditioning reduces blood pressure and normalizes nitric oxide synthesis in patients with arterial hypertension". J Hypertens. 29 (11): 2265–2272. doi:10.1097/HJH.0b013e32834b5846. PMID   21897291. S2CID   28868197.
  14. 1 2 Guner, I.; Uzun, D.D.; Yaman, M.O.; Genc, H.; Gelisgen, R.; Korkmaz, G.G.; Hallac, M.; Yelman, N.; Sahin, G.; Karter, Y.; Simsek, G. (2013). "The effect of chronic long-term intermittent hypobaric hypoxia on bone mineral density in rats: role of nitric oxide". Biol Trace Elem Res. 154 (2): 262–267. doi:10.1007/s12011-013-9722-8. PMID   23771686. S2CID   14365564.
  15. ↑ Baker, T.L.; Mitchell, G.S. (2000). "Episodic but not continuous hypoxia elicits long-term facilitation of phrenic motor output in rats". J Physiol. 529 (1): 215–219. doi:10.1111/j.1469-7793.2000.00215.x. PMC   2270180 . PMID   11080263.
  16. 1 2 Lovett-Barr, M.R.; Satriotomo, I.; Muir, G.D.; Wilkerson, J.E.; Hoffman, M.S.; Vinit, S.; Mitchell, G.S. (2012). "Repetitive intermittent hypoxia induces respiratory and somatic motor recovery after chronic cervical spinal injury". J Neurosci. 32 (11): 3591–3600. doi:10.1523/JNEUROSCI.2908-11.2012. PMC   3349282 . PMID   22423083.
  17. ↑ Gerst, D.G.; 3rd Yokohana, S.S.; Carney, L.M.; Lee, D.S.; Badr, M.S.; Qureshi, T.; Anthouard, M.N.; Mateika, J.H. (2011). "The hypoxic ventilatory response and ventilatory long-term facilitation are altered by time of day and repeated daily exposure to intermittent hypoxia". J Appl Physiol. 110 (1): 15–28. doi:10.1152/japplphysiol.00524.2010. PMC   3785116 . PMID   20724571.
  18. ↑ Haider, T.; Casucci, G.; Linser, T.; Faulhaber, M.; Gatterer, H.; Ott, G.; Linser, A.; Ehrenbourg, I.; Tkatchouk, E.; Burtscher, M.; Bernardi, L. (2009). "Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease". J Hypertens. 27 (8): 1648–1654. doi:10.1097/HJH.0b013e32832c0018. PMID   19387363. S2CID   11277060.
  19. ↑ Hayes, H.B.; Jayataman, A.; Herrmann, M.; Mitchell, G.S.; Rymer, W.Z.; Trumbower, R.D. (2014). "Daily intermittent hypoxia enhances walking after chronic spinal cord injury: A randomized trial". Neurology. 82 (2): 104–113. doi:10.1212/01.WNL.0000437416.34298.43. PMC   3897437 . PMID   24285617.
  20. ↑ Lu, X.J.; Chen, X.Q.; Weng, J.; Zhang, H.Y.; Pak, D.T.; Luo, J.H.; Du, J.Z. (2009). "Hippocampal spine-associated Rap-specific GTPase-activating protein induces enhancement of learning and memory in postnatally hypoxia-exposed mice". Neuroscience. 162 (2): 404–414. doi:10.1016/j.neuroscience.2009.05.011. PMC   3243647 . PMID   19442707.
  21. ↑ Zhang, J.X.; Chen, X.Q.; Du, J.Z.; Chen, Q.M.; Zhu, C.Y. (2005). "Neonatal exposure to intermittent hypoxia enhances mice performance in water maze and 8-arm radial maze tasks". J Neurobiol. 65 (1): 72–84. doi:10.1002/neu.20174. PMID   16010673.
  22. ↑ Shao, G.; Zhang, R.; Wang, Z.L.; Gao, C.Y.; Huo, X.; Lu, G.W. (2006). "Hippocampal spine-associated Rap-specific GTPase-activating protein induces enhancement of learning and memory in postnatally hypoxia-exposed mice". Neuro-Signals. 15 (6): 314–321. doi: 10.1159/000121368 . PMID   18349553.
  23. ↑ Zhu, X.H.; Yan, H.C.; Zhang, J.; Qu, H.D.; Qiu, X.S.; Chen, L.; Li, S.J.; Cao, X.; Bean, J.C.; Chen, L.H.; Qin, X.H.; Liu, J.H.; Bai, X.C.; Mei, L.; Gao, T.M. (2010). "Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats". J Neurosci. 30 (38): 12653–12663. doi:10.1523/JNEUROSCI.6414-09.2010. PMC   6633584 . PMID   20861371.
  24. ↑ Shatillo, V.B.; Korkushko, O.V.; Ischuk, V.A.; Downey, H.F.; Serebrovskaya, T.V. (2008). "Effects of intermittent hypoxia training on exercise performance, hemodynamics, and ventilation in healthy senior men". High Alt Med Biol. 9 (1): 43–52. doi:10.1089/ham.2008.1053. PMID   18331220.
  25. ↑ Bolli, R. (2001). "Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research". J Mol Cell Cardiol. 33 (11): 1897–1918. doi:10.1006/jmcc.2001.1462. PMID   11708836.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.